Aug 12, 2020
Chemotherapy-induced Nausea & Vomiting Drugs Market, 2024 - Focus on Serotonin & NK1 Receptor Antagonists and Other Therapies
Jun 10, 2020
Gastroparesis Market Analysis for the 7MM - Epidemiology and Forecasts to 2028
May 06, 2020
Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids
Apr 27, 2020
New Player Cantourage Challenges Canopy Growth on Dronabinol Cannabis Monopoly in Europe
Apr 13, 2020
Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer
Apr 08, 2020
MMJ International Holdings Ships First-Ever Marijuana Extracts to USA
Mar 23, 2020
A first-of-its-kind permit to export cannabis oil from the US to Israel was granted to Panaxia and its partner Ultra Health
Mar 18, 2020
Washington, DC, Vermont, and Colorado Lead the Online CBD Revolution, New Data Shows
Mar 09, 2020
Senzer Secures US Clinical Data Package for the Treatment of Chemotherapy Induced Adverse Events
Mar 02, 2020
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
Feb 20, 2020
Health Canada-DEA Approves MMJ International Holdings To Ship THC
Feb 19, 2020
MinnMed Offers State's First eCommerce Shop to Make Medical Cannabis More Accessible for Minnesotans
Feb 18, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
Jan 27, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit
Jan 13, 2020
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Jan 13, 2020
Upsher-Smith Launches Haloperidol Tablets, USP
Jan 07, 2020
MMJ International Holdings Overcomes Big Federal Deterrents In It's Marijuana Drug Development Strategy
Dec 18, 2019
Panaxia Announces Positive Top-Line Results From Its Clinical Trial In Leading Medical Cannabis Products
Dec 09, 2019
Olympic Hall of Fame Inductee Gary Hall Jr. Joins C3 International Board of Advisors
Dec 03, 2019
Zelira Therapeutics Expands HOPE® Distribution In The U.S.A